Eligo Bioscience forges ahead with new acne treatment after

Eligo Bioscience, a gene-editing company focused on addressing diseases driven by the expression of bacterial genes from the microbiome, has announced a successful $30 million Series B funding round, led by Sanofi Ventures.

Related Keywords

Benoit Barteau , Eligo Bioscience , Xavier Duportet , , Khosla Ventures , Laia Crespo , Sanofi Venture , Markets Amp Regulations , Bio Developments , Pipelines , Emerging Markets , Icrobiome , Bacteria , Funding ,